Difference between revisions of "Part:BBa K4634010:Design"
NgSweeHong (Talk | contribs) (→References) |
|||
Line 16: | Line 16: | ||
===References=== | ===References=== | ||
+ | Gurbatri CR, Lia I, Vincent R, Coker C, Castro S, Treuting PM, Hinchliffe TE, Arpaia N, Danino T. Engineered probiotics for local tumor delivery of checkpoint blockade nanobodies. Sci Transl Med. 2020 Feb 12;12(530):eaax0876. doi: 10.1126/scitranslmed.aax0876. PMID: 32051224; PMCID: PMC7685004. |
Latest revision as of 17:40, 6 October 2023
PD-L1 nanobody
Assembly Compatibility:
- 10INCOMPATIBLE WITH RFC[10]Illegal PstI site found at 247
- 12INCOMPATIBLE WITH RFC[12]Illegal PstI site found at 247
Illegal NotI site found at 200 - 21COMPATIBLE WITH RFC[21]
- 23INCOMPATIBLE WITH RFC[23]Illegal PstI site found at 247
- 25INCOMPATIBLE WITH RFC[25]Illegal PstI site found at 247
Illegal AgeI site found at 25 - 1000COMPATIBLE WITH RFC[1000]
Design Notes
NA
Source
https://www.rcsb.org/structure/5DXW
References
Gurbatri CR, Lia I, Vincent R, Coker C, Castro S, Treuting PM, Hinchliffe TE, Arpaia N, Danino T. Engineered probiotics for local tumor delivery of checkpoint blockade nanobodies. Sci Transl Med. 2020 Feb 12;12(530):eaax0876. doi: 10.1126/scitranslmed.aax0876. PMID: 32051224; PMCID: PMC7685004.